<DOC>
	<DOCNO>NCT01603030</DOCNO>
	<brief_summary>This Unicentric , double-blind , randomize , two-arm , parallel-group study demonstrate efficacy moxifloxacin/prednisolone acetate fix combination compare individual administration moxifloxacin + acetate Prednisolone Eye drop Prevention Post Operative Inflammation Infection LASIK surgery .</brief_summary>
	<brief_title>Efficacy Moxifloxacin/Prednisolone Prevention Post Surgery Inflammation</brief_title>
	<detailed_description>antibiotic/steroid combination compare individual component 15 day treatment</detailed_description>
	<mesh_term>Inflammation</mesh_term>
	<mesh_term>Eye Infections</mesh_term>
	<mesh_term>Prednisolone acetate</mesh_term>
	<mesh_term>Methylprednisolone acetate</mesh_term>
	<mesh_term>Prednisolone</mesh_term>
	<mesh_term>Methylprednisolone</mesh_term>
	<mesh_term>Methylprednisolone Hemisuccinate</mesh_term>
	<mesh_term>Prednisolone hemisuccinate</mesh_term>
	<mesh_term>Prednisolone phosphate</mesh_term>
	<mesh_term>Moxifloxacin</mesh_term>
	<mesh_term>Fluoroquinolones</mesh_term>
	<mesh_term>Norgestimate , ethinyl estradiol drug combination</mesh_term>
	<criteria>Men woman race , 18 50 year age 8 degree myopia hyperopia 04 degree 3 degree without astigmatism eye problem associate . Able understand provide inform consent , Willingness complete require study visit , Willingness undergo surgery correct grade ( myopia , astigmatism , hyperopia ) LASIK eye ( surgical surgical procedure separate ) one eye . Examination normal fundus direct ophthalmoscopy indirect ; Measurements intraocular pressure ( IOP ) , treat untreated , less equal 20 mmHg . Individuals glaucoma / ocular hypertension eligible blood pressure control single ocular hypotensive agent exception note criterion exclusion . 16 . Women may become pregnant ( surgically sterile postmenopausal ) may participate study meet following condition : ) breastfeeding ; b ) negative pregnancy test screen prior recruitment ; c ) agree submit urine test pregnancy time withdrawal study ; ) conceive study period ; e ) use birth control method appropriate agrees continue use birth control method appropriate duration study ( method birth control adequate : hormonal contraceptive oral , implantable injectable ; mechanic spermicide associate barrier method like condom diaphragm , IUD , sterilization partner ) . Glaucoma intraocular hypertension control ; Use nonsteroidal antiinflammatory drug ( NSAIDs ) ocular topical systemic drug ( NSAIDs ) study 14 day prior study entry , except allow daily dose aspirin lowdose ( 100 mg ) ; Ocular antiinfective drug use study within 30 day prior study entry eye medicine exception note criterion Insertion 6 . Topical steroid , inhaled systemic ocular study 14 day prior study entry ; Ocular trauma eye prior operate ( include intraocular surgery previous twelve month due trauma cataract past ) ; History chronic ocular inflammatory disease recurrent ( ie , iritis , scleritis , uveitis , iridocyclitis , rubeosis iridis ) eye operate ; Any intraocular inflammation ( score cell Grade 0 ) present examination slit lamp ocular pain increase Grade 1 2 Day study eye ( eye operation ) ; Proliferative diabetic retinopathy ( eye operation ) nonproliferative diabetic retinopathy , moderate severe ( eye operation ) ; Uncontrolled diabetes mellitus ; Patients vision one eye vision correctable LogMAR 1.0 good eye use ETDRS framework ; Participation clinical study within 12 month prior surgery , pregnant woman , lactate condition breed method use adequate birth control ( define criterion inclusion , ) ; Known suspect allergy hypersensitivity moxifloxacin , steroid , topical anesthetic component study medication ; History evidence severe illness , systemic condition may cause patient , opinion Investigator , study inadequate ; Patients epithelial herpes simplex ( dendritic keratitis ) , vaccinia , varicella , viral disease cornea conjunctiva , tuberculosis eye , fungal disease ocular structure ; Patients use topical ophthalmic prostaglandin , , Travatan速 ( travoprost ) , Xalatan速 ( latanoprost ) , Lumigan速 ( bimatoprost ) Rescula速 ( unoprostone ) discontinue use start four day surgery departure study .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>50 Years</maximum_age>
	<verification_date>May 2012</verification_date>
	<keyword>Moxifloxacin</keyword>
	<keyword>Prednisolone</keyword>
	<keyword>LASIK</keyword>
</DOC>